FR2514646A1 - A titre de medicament protegeant ou restaurant la formule sanguine blanche, notamment la lignee lymphocytaire, le desoxyribonucleinate de magnesium et son association avec la fraction antitoxique du foie - Google Patents

A titre de medicament protegeant ou restaurant la formule sanguine blanche, notamment la lignee lymphocytaire, le desoxyribonucleinate de magnesium et son association avec la fraction antitoxique du foie Download PDF

Info

Publication number
FR2514646A1
FR2514646A1 FR8119497A FR8119497A FR2514646A1 FR 2514646 A1 FR2514646 A1 FR 2514646A1 FR 8119497 A FR8119497 A FR 8119497A FR 8119497 A FR8119497 A FR 8119497A FR 2514646 A1 FR2514646 A1 FR 2514646A1
Authority
FR
France
Prior art keywords
sep
magnesium
liver
chloramphenicol
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8119497A
Other languages
English (en)
French (fr)
Other versions
FR2514646B3 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8119497A priority Critical patent/FR2514646A1/fr
Publication of FR2514646A1 publication Critical patent/FR2514646A1/fr
Application granted granted Critical
Publication of FR2514646B3 publication Critical patent/FR2514646B3/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8119497A 1981-10-16 1981-10-16 A titre de medicament protegeant ou restaurant la formule sanguine blanche, notamment la lignee lymphocytaire, le desoxyribonucleinate de magnesium et son association avec la fraction antitoxique du foie Granted FR2514646A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8119497A FR2514646A1 (fr) 1981-10-16 1981-10-16 A titre de medicament protegeant ou restaurant la formule sanguine blanche, notamment la lignee lymphocytaire, le desoxyribonucleinate de magnesium et son association avec la fraction antitoxique du foie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8119497A FR2514646A1 (fr) 1981-10-16 1981-10-16 A titre de medicament protegeant ou restaurant la formule sanguine blanche, notamment la lignee lymphocytaire, le desoxyribonucleinate de magnesium et son association avec la fraction antitoxique du foie

Publications (2)

Publication Number Publication Date
FR2514646A1 true FR2514646A1 (fr) 1983-04-22
FR2514646B3 FR2514646B3 (OSRAM) 1984-06-29

Family

ID=9263112

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8119497A Granted FR2514646A1 (fr) 1981-10-16 1981-10-16 A titre de medicament protegeant ou restaurant la formule sanguine blanche, notamment la lignee lymphocytaire, le desoxyribonucleinate de magnesium et son association avec la fraction antitoxique du foie

Country Status (1)

Country Link
FR (1) FR2514646A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357958A3 (en) * 1988-08-04 1990-12-12 Schwarz Pharma Ag Pharmaceutical preparation against viral diseases comprising a liver extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357958A3 (en) * 1988-08-04 1990-12-12 Schwarz Pharma Ag Pharmaceutical preparation against viral diseases comprising a liver extract

Also Published As

Publication number Publication date
FR2514646B3 (OSRAM) 1984-06-29

Similar Documents

Publication Publication Date Title
EP0336851B1 (fr) Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique
JP2002504514A (ja) 肝臓傷害の予防、治療及び修復のためのｌ−エルゴチオネイン、ノゲシ及びｓ−アデノシルメテオニン
JP2002526407A (ja) フルボ酸、および種々の状態の処置におけるその使用
FR2508797A1 (fr) Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
CA2107078A1 (fr) Utilisation de la riboflavine dans le traitement de maladies liees aux virus vih, de l'herpes, de la retinite pigmentaire et du paludisme
EP0530060B1 (fr) Médicament à base de dérivés soufrés neutralisés
US7256202B2 (en) Composition and method for treatment of hepatic encephalopathy
LONGCOPE et al. The use of BAL (British anti-Lewisite) in the treatment of the injurious effects of arsenic, mercury and other metallic poisons
US3560612A (en) Method of alleviating hypercitricemia
EP4061398A1 (fr) Extrait liquide aqueux de spiruline pour la prévention et/ou le traitement des neuropathies périphériques chimio-induites et leurs symptômes, composition et utilisation correspondantes
FR2601678A1 (fr) Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
EP1970372B1 (en) Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols
FR2514646A1 (fr) A titre de medicament protegeant ou restaurant la formule sanguine blanche, notamment la lignee lymphocytaire, le desoxyribonucleinate de magnesium et son association avec la fraction antitoxique du foie
Allen et al. The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves
Losito et al. Metabolic studies of vitamin K1-14C and menadione-14C in the normal and hepatectomized rats
JPH06199695A (ja) 糖尿病改善治療剤
Tedesco et al. Free amino acids in Citrullus vulgaris (watermelon)
EP0113608A1 (fr) Association permettant d'améliorer l'absorption de divers cations
KR100266929B1 (ko) 약학적 라이신-함유 폴리펩티드 조성물 및 그의 사용방법
FR2485371A1 (fr) Nouvelle composition a usage therapeutique a base de lysine et d'arginine
US5087639A (en) Preventing CNS toxicity of acivicin when used with four large neutral amino acids
GB2194885A (en) Pharmaceutical compositions containing vanadium
KR20020031404A (ko) 혈장 대체 조성물
EP1317922A1 (fr) Preparation antipyretique renfermant du xylitol
Dockrell et al. Hypercalcemia in a patient with hypoparathyroidism and Nocardia asteroides infection: a novel observation